Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in developing lumateperone, which is in Phase III clinical trial for the treatment of bipolar depression, as well as to treat autism spectrum disorder; and in additional neuropsychiatric indications, such as sleep disorders associated with neuropsychiatric and neurological disorders. In addition, the company is developing Lenrispodun (ITI-214) for the treatment of Parkinson's disease and heart failure; ITI-1284-ODT-SL for the treatment of neuropsychiatric disorders and behavioral disturbances in dementia; and ITI-333 for substance use disorders, pain, and psychiatric comorbidities, including depression and anxiety. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Intra-Cellular Therapies Inc..
Intra-Cellular Therapies Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Intra-Cellular Therapies Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Intra-Cellular Therapies Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Intra-Cellular Therapies Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Intra-Cellular Therapies Inc. and all latest updates of the company are provided.
The 2025 version of Intra-Cellular Therapies Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Intra-Cellular Therapies Inc.- Key Facts
2.2 Intra-Cellular Therapies Inc.- Geographic Locations
2.3 Intra-Cellular Therapies Inc.- Subsidiaries and Affiliates
2.4 Intra-Cellular Therapies Inc.- Business Divisions
2.5 Intra-Cellular Therapies Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Intra-Cellular Therapies Inc. Strategic Analysis Review
3.1 Intra-Cellular Therapies Inc.- Key Strategies
3.2 Intra-Cellular Therapies Inc.- Company Outlook Statement
3.3 Intra-Cellular Therapies Inc.- SWOT Analysis
3.3.1 Intra-Cellular Therapies Inc.- Key Strengths
3.3.2 Intra-Cellular Therapies Inc.- Key Weaknesses
3.3.3 Intra-Cellular Therapies Inc.- Potential Opportunities
3.3.4 Intra-Cellular Therapies Inc.- Potential Threats
3.4 Intra-Cellular Therapies Inc.- Key Competitors
4. Business Description of the Company
4.1 Intra-Cellular Therapies Inc.- Business Overview
4.2 Intra-Cellular Therapies Inc.- Operations by Segment
5 Products and Services Details
5.1 Intra-Cellular Therapies Inc.- Key Products
5.2 Intra-Cellular Therapies Inc.- Key Service Areas
5.3 Intra-Cellular Therapies Inc.- Key Brands
6 Company Developments
6.1 Intra-Cellular Therapies Inc.- Company History
6.2 Intra-Cellular Therapies Inc.- Latest Developments
7 Financial Analysis
7.1 Intra-Cellular Therapies Inc.- Income Statements
7.2 Intra-Cellular Therapies Inc.- Balance Sheet
7.3 Intra-Cellular Therapies Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Intra-Cellular Therapies Inc.- Direct Competitors
8.2 Intra-Cellular Therapies Inc.- Competitor Financial Ratios comparison
8.3 Intra-Cellular Therapies Inc.- Competitor Stock Charts Comparison
8.4 Intra-Cellular Therapies Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!